Literature DB >> 26957994

Comparison of the inhibition capability of oleanolic acid and betulinic acid towards drug-metabolizing enzymes.

Wei Xiao1, Meng-Hou Lu1.   

Abstract

BACKGROUND: Human UDP-glucuronosyltransferases (UGTs) are important membrane proteins located in endoplasmic reticulum, and play important roles in metabolism of a variety of endogenous and exogenous compounds. AIMS: To determine the influence of subtle difference in the structure of oleanolic acid and betulinic acid towards the inhibition towards the activity of UGT isoforms.
METHODS: In vitro glucuronidation of 4-methylumbelliferone (4-MU) reaction was employed as the probe reaction to determine the inhibition of these two compounds towards UGTs' activity.
RESULTS: The inhibition of capability of oleanolic acid towards UGT1A6 and UGT1A8 were higher than betulinic acid. However, no significant difference was observed for the inhibition of oleanolic acid and betulinic acid towards UGT1A7. Furthermore, concentration-dependent behaviour was determined for the inhibition of oleanolic acid and betulinic acid towards UGT1A6 and UGT1A8. At various concentrations of oleanolic acid and betulinic acid, the inhibition of oleanolic acid towards UGT1A6 and UGT1A8 was higher than betulinic acid. CONSLUSION: Given that UGT1A6 and UGT1A8 play key role in the the inhibition of oleanolic acid towards UGT1A6 and UGT1A8 will induce drug-drug interaction and the risk of diseases.

Entities:  

Keywords:  UDP-glucuronosyltransferases(UGTs); betulinic acid; drug-drug interaction; oleanolic acid

Mesh:

Substances:

Year:  2015        PMID: 26957994      PMCID: PMC4765439          DOI: 10.4314/ahs.v15i3.40

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


  14 in total

1.  Warfarin is an effective modifier of multiple UDP-glucuronosyltransferase enzymes: evaluation of its potential to alter the pharmacokinetics of zidovudine.

Authors:  Hua Sun; Tianpeng Zhang; Zhufeng Wu; Baojian Wu
Journal:  J Pharm Sci       Date:  2014-11-12       Impact factor: 3.534

2.  Arbidol exhibits strong inhibition towards UDP-glucuronosyltransferase (UGT) 1A9 and 2B7.

Authors:  Xin Liu; Ting Huang; Jian-Xing Chen; Jia Zeng; Xu-Ran Fan; Zhen-Wen Yu; Xiao-Yu Sun; Mo Hong; Hong-Zhi Sun
Journal:  Pharmazie       Date:  2013-12       Impact factor: 1.267

3.  High enzyme activity UGT1A1 or low activity UGT1A8 and UGT2B4 genotypes increase esophageal cancer risk.

Authors:  Polat Dura; Jody Salomon; Rene H M Te Morsche; Hennie M J Roelofs; Jon O Kristinsson; Theo Wobbes; Ben J M Witteman; Adriaan C I T L Tan; Joost P H Drenth; Wilbert H M Peters
Journal:  Int J Oncol       Date:  2012-02-22       Impact factor: 5.650

4.  Tacrolimus strongly inhibits multiple human UDP-glucuronosyltransferase (UGT) isoforms.

Authors:  Xiao-You Liu; Zhong-Ze Fang; Pei-Pei Dong; Xiang-Hua Shi; Yan-Jie Teng; Xu-Yong Sun
Journal:  Pharmazie       Date:  2012-09       Impact factor: 1.267

5.  Oleanolic acid suppresses the proliferation of lung carcinoma cells by miR-122/Cyclin G1/MEF2D axis.

Authors:  Xiaoming Zhao; Ming Liu; Daotang Li
Journal:  Mol Cell Biochem       Date:  2014-12-04       Impact factor: 3.396

6.  Using a reporting system to protect the human rights of people living with HIV and key populations: a conceptual framework.

Authors:  R Taylor Williamson; Peter Wondergem; Richard N Amenyah
Journal:  Health Hum Rights       Date:  2014-06-14

7.  Betulinic acid, a bioactive pentacyclic triterpenoid, inhibits skeletal-related events induced by breast cancer bone metastases and treatment.

Authors:  Se Young Park; Hyun-Jeong Kim; Ki Rim Kim; Sun Kyoung Lee; Chang Ki Lee; Kwang-Kyun Park; Won-Yoon Chung
Journal:  Toxicol Appl Pharmacol       Date:  2014-01-24       Impact factor: 4.219

Review 8.  Nuclear receptors and endobiotics glucuronidation: the good, the bad, and the UGT.

Authors:  Cyril Bigo; Sarah Caron; Amélie Dallaire-Théroux; Olivier Barbier
Journal:  Drug Metab Rev       Date:  2013-02       Impact factor: 4.518

9.  New betulinic acid derivatives for bevirimat-resistant human immunodeficiency virus type-1.

Authors:  Zhao Dang; Phong Ho; Lei Zhu; Keduo Qian; Kuo-Hsiung Lee; Li Huang; Chin-Ho Chen
Journal:  J Med Chem       Date:  2013-02-20       Impact factor: 7.446

10.  The HIV mutation browser: a resource for human immunodeficiency virus mutagenesis and polymorphism data.

Authors:  Norman E Davey; Venkata P Satagopam; Salvador Santiago-Mozos; Carlos Villacorta-Martin; Tanmay A M Bharat; Reinhard Schneider; John A G Briggs
Journal:  PLoS Comput Biol       Date:  2014-12-04       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.